Literature DB >> 22027748

Diagnostic implications of p16 expression in serous papillary endometrial cancer.

Itamar M Netzer1, Hedwiga Kerner, Ludmila Litwin, Lior Lowenstein, Amnon Amit.   

Abstract

OBJECTIVE: The purpose of this study was to examine whether the degree of expression of the p16 protein in serous papillary endometrial cancer bears a prognostic significance. The secondary objective was to establish the value of p16 immunohistochemical staining as an adjunct to diagnosis. STUDY
DESIGN: Archived paraffin blocks holding specimens from the uteri of 31 serous papillary and 31 endometrioid endometrial carcinoma patients were recut and restained for p16 and p53.
RESULTS: Overexpression of p16 was found in 78% of the serous papillary patients versus 36% of the endometrioid patients. p16 was not found to be an independent prognostic factor in serous papillary endometrial carcinoma.
CONCLUSIONS: Although p16 was not found to have prognostic significance in serous papillary endometrial carcinoma, it may be valuable as a diagnostic adjunct in histologically ambiguous tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22027748     DOI: 10.1097/IGC.0b013e31822eee04

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  The genomics and genetics of endometrial cancer.

Authors:  Andrea J O'Hara; Daphne W Bell
Journal:  Adv Genomics Genet       Date:  2012-03

2.  A "Null" Pattern of p16 Immunostaining in Endometrial Serous Carcinoma: An Under-recognized and Important Aberrant Staining Pattern.

Authors:  Daniel R Matson; Molly A Accola; Les Henderson; Xiangqiang Shao; Leah Frater-Rubsam; Vanessa L Horner; William M Rehrauer; Paul Weisman; Jin Xu
Journal:  Int J Gynecol Pathol       Date:  2021-08-11       Impact factor: 3.326

Review 3.  Signalling pathways in endometrial cancer.

Authors:  Anna Markowska; Monika Pawałowska; Jolanta Lubin; Janina Markowska
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-18

Review 4.  The significance of markers in the diagnosis of endometrial cancer.

Authors:  Monika M Żyła; Jacek R Wilczyński; Marta Kostrzewa; Kinga Księżakowska-Łakoma; Marek Nowak; Grzegorz Stachowiak; Krzysztof Szyłło; Tomasz Stetkiewicz
Journal:  Prz Menopauzalny       Date:  2016-11-15

5.  Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.

Authors:  Zhen Xiao; Yingying He; Chongya Liu; Lin Xiang; Jingyan Yi; Min Wang; Tingting Shen; Lanlin Shen; Yijue Xue; Hong Shi; Pixu Liu
Journal:  Oncol Rep       Date:  2019-03-14       Impact factor: 3.906

6.  Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer.

Authors:  Zhen Liu; Zhipan Hong; Pengpeng Qu
Journal:  Biomed Res Int       Date:  2020-08-22       Impact factor: 3.411

7.  ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

Authors:  Nicoletta Colombo; Carien Creutzberg; Frederic Amant; Tjalling Bosse; Antonio González-Martín; Jonathan Ledermann; Christian Marth; Remi Nout; Denis Querleu; Mansoor Raza Mirza; Cristiana Sessa
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.